SCHEMBL6479833

SCHEMBL6479833

CCC(NC(=O)c1ccc2[nH]c(-c3cc[nH]n3)cc2c1)c1cc(O)[nH]n1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.37
IKBKB O14920 4/20 0.36
ITK Q08881 3/20 0.36
MAPK1 P28482 2/20 0.35
MAPK3 P27361 1/20 0.35
ROCK2 O75116 2/20 0.34
TAS1R3 Q7RTX0 3/20 0.33
TAS1R1 Q7RTX1 3/20 0.33
CDK2 P24941 2/20 0.33
INSR P06213 1/20 0.33
CCNE1 P24864 1/20 0.33
PAK4 O96013 1/20 0.32
ROCK1 Q13464 1/20 0.32
PPARG P37231 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
CHEK1 O14757 1/20 0.32
CDK7 P50613 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6487361 0.93 ITK (0.44) ITKROCK2TAS1R3TAS1R1CDK2
SCHEMBL5755558 0.81 HDAC6 (0.48) HDAC6IKBKBITKROCK2TAS1R3
SCHEMBL6478728 0.81 TACR3 (0.34) ITKMAPK1MAPK3KDM4EALDH1A1
SCHEMBL5755542 0.78 RIPK1 (0.44) HDAC6IKBKBITKROCK2CDK2
SCHEMBL5759216 0.76 ITK (0.51) HDAC6IKBKBITKCHEK1CDK7
SCHEMBL5756790 0.76 RIPK1 (0.46) HDAC6ITKKDM4EALDH1A1MAPT
SCHEMBL5754329 0.75 KMT2A (0.45) HDAC6IKBKBITKTAS1R3TAS1R1
SCHEMBL6479843 0.75 ITK (0.39) HDAC6ITKKDM4EALDH1A1MAPT
SCHEMBL5753446 0.74 KDM4E (0.48) HDAC6ITKKDM4EALDH1A1MAPT
SCHEMBL6489873 0.74 ITK (0.41) HDAC6IKBKBITKMAPK1TAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 HDAC6 739/4885IKBKB 372/4885ITK 392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.